Friday, December 6, 2019
Korea Exchange Pitches KOSDAQ Market to Top-tier U.S. Biotech Companies
Presenting KOSDAQ to Participants in Bio USA
Korea Exchange Pitches KOSDAQ Market to Top-tier U.S. Biotech Companies
  • By Choi Moon-hee
  • June 10, 2019, 10:08
Share articles

Kim Sung-tae, managing director of Korea Exchange KOSDAQ market, explains KOSDAQ listing to biotech companies at 2019 Road to KOSDAQ IPO seminar held in Philadelphia, United States on June 5 (local time).

Korea Exchange said on June 7 that it has recently visited the United States to attract top-tier global biotechnology companies.

The KOSDAQ market headquarters participated in the 2019 Bio International Convention (also called Bio USA) held in Philadelphia, United States from June 3-6 (local time) to promote the KOSDAQ market to biotech companies.

Bio USA is the world's largest pharmaceutical and biotech conference held every year since 1993. This year, about 70 pharmaceutical and biotech companies and more than 16,000 industry people from around the world attended the event. The KOSDAQ Market Headquarters held a briefing session on the status of the KOSDAQ market and KOSDAQ listing system for foreign companies.

Korea Exchange visited prospective companies in the eastern United States to give customized consulting on the KOSDAQ listing procedures and preparations.